Halozyme Therapeutics shares owned by Boussard & Gavaudan Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Boussard & Gavaudan Investment Management
from 13F filings
Historical chart of Boussard & Gavaudan Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Boussard & Gavaudan Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $22M | 20k | 1147.87 |
| 2025-06-30 | $35M | 35k | 999.16 |
| 2025-03-31 | $16M | 15k | 1058.28 |
| 2024-09-30 | $13M | 13k | 1004.58 |
| 2024-06-30 | $6.7M | 7.0k | 952.18 |
More positions owned by Boussard & Gavaudan Investment Management
View all positions for Boussard & Gavaudan Investment Management